פלואד

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE VIRUS; A/HONG KONG/4801/2014 (H3N2) - LIKE VIRUS; B/BRISBANE/60/2008 - LIKE VIRUS

Commercializzato da:

NEOPHARM SCIENTIFIC LTD

Codice ATC:

J06BB07

Forma farmaceutica:

תרחיף להזרקה

Composizione:

B/BRISBANE/60/2008 - LIKE VIRUS 15 MCG / 0.5 ML; A/HONG KONG/4801/2014 (H3N2) - LIKE VIRUS 15 MCG / 0.5 ML; A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE VIRUS 15 MCG / 0.5 ML

Via di somministrazione:

תוך-שרירי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

SEQIRUS VACCINES LTD, UK

Gruppo terapeutico:

VACCINIA IMMUNOGLOBULIN

Area terapeutica:

VACCINIA IMMUNOGLOBULIN

Indicazioni terapeutiche:

Active immunisation against influenza in theelderly (65 years of age and over), especially for those with an infreased risk of associated complications (i.e. patients affected by underlying chronic diseases including diabetes, cardiovascular and respiratory diseases).

Data dell'autorizzazione:

2015-12-31